COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 49 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,671,195 | +2.1% | 209,002 | -1.8% | 0.00% | 0.0% |
Q2 2023 | $4,573,438 | +62.9% | 212,817 | +81.8% | 0.00% | 0.0% |
Q1 2023 | $2,807,574 | +37.2% | 117,031 | +32.7% | 0.00% | – |
Q4 2022 | $2,045,961 | +23.8% | 88,188 | -14.5% | 0.00% | – |
Q3 2022 | $1,652,000 | +52.5% | 103,109 | +68.7% | 0.00% | – |
Q2 2022 | $1,083,000 | -47.2% | 61,121 | -39.4% | 0.00% | – |
Q1 2022 | $2,052,000 | -25.8% | 100,803 | -31.9% | 0.00% | -100.0% |
Q4 2021 | $2,767,000 | -24.2% | 148,120 | -19.9% | 0.00% | 0.0% |
Q3 2021 | $3,651,000 | -12.9% | 184,970 | +4.3% | 0.00% | 0.0% |
Q2 2021 | $4,193,000 | -6.9% | 177,385 | -6.6% | 0.00% | 0.0% |
Q1 2021 | $4,503,000 | +239.1% | 189,997 | +186.5% | 0.00% | – |
Q4 2020 | $1,328,000 | +41.4% | 66,319 | +47.0% | 0.00% | – |
Q3 2020 | $939,000 | -31.3% | 45,126 | -42.2% | 0.00% | – |
Q2 2020 | $1,367,000 | -36.8% | 78,131 | -41.0% | 0.00% | -100.0% |
Q1 2020 | $2,163,000 | -57.3% | 132,498 | -46.2% | 0.00% | 0.0% |
Q4 2019 | $5,065,000 | +444.6% | 246,153 | +204.0% | 0.00% | – |
Q3 2019 | $930,000 | -25.0% | 80,980 | -14.1% | 0.00% | – |
Q2 2019 | $1,240,000 | -54.0% | 94,271 | -47.1% | 0.00% | -100.0% |
Q1 2019 | $2,697,000 | -26.0% | 178,173 | -16.0% | 0.00% | 0.0% |
Q4 2018 | $3,643,000 | -25.5% | 212,157 | -36.1% | 0.00% | 0.0% |
Q3 2018 | $4,891,000 | +87.5% | 331,785 | +203.3% | 0.00% | 0.0% |
Q2 2018 | $2,608,000 | +84.4% | 109,377 | +97.6% | 0.00% | – |
Q1 2018 | $1,414,000 | -31.6% | 55,353 | -50.6% | 0.00% | – |
Q4 2017 | $2,068,000 | +87.5% | 112,024 | +6.5% | 0.00% | – |
Q3 2017 | $1,103,000 | +20.3% | 105,217 | +43.5% | 0.00% | – |
Q2 2017 | $917,000 | +0.8% | 73,310 | -18.9% | 0.00% | – |
Q1 2017 | $910,000 | +64.0% | 90,377 | +153.5% | 0.00% | – |
Q4 2016 | $555,000 | +150.0% | 35,646 | +208.7% | 0.00% | – |
Q3 2016 | $222,000 | -57.5% | 11,546 | -73.8% | 0.00% | – |
Q2 2016 | $522,000 | -52.3% | 44,088 | -26.9% | 0.00% | – |
Q1 2016 | $1,094,000 | -2.6% | 60,294 | +47.7% | 0.00% | – |
Q4 2015 | $1,123,000 | +55.8% | 40,834 | +1.0% | 0.00% | – |
Q2 2015 | $721,000 | – | 40,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |